01/01/2023
Laboratoriumgeneeskunde
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee.
European Radiology 2023 doi: 10.1007/s00330-023-10411-xdr. Langlois Michel01/01/2023
Laboratoriumgeneeskunde
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network.
Atherosclerosis 2023;370:5-11. doi: 10.1016/j.atherosclerosis.2023.02.007dr. Langlois Michel01/01/2023
Laboratoriumgeneeskunde
Analytical interference of intravascular contrast agents with clinical laboratory tests: a joint guideline by the ESUR Contrast Media Safety Committee and the Preanalytical Phase Working Group of the EFLM Science Committee.
Clin Chem Lab Med 2023 doi: 10.1515/cclm-2023-1184.dr. Langlois Michel01/01/2023
Laboratoriumgeneeskunde
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.
J Am Heart Assoc. 2023;12:e030405. doi: 10.1161/JAHA.123.030405dr. Langlois Michel01/01/2015
Endocrinologie
Bone scan alterations in aromatase inhibitor-treated patients.
Clin Nucl Med. 2015 Jan;40(1):38-40. doi: 10.1097/RLU.0000000000000588. PMID: 25290288dr. Van den Bruel Annickdr. De Cuypere Evelinedr. De Geeter Frankdr. Langlois Michel01/01/2009
Endocrinologie
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients.
Clin Chem Lab Med. 2009;47(5):604-6. PMID: 19397486dr. Van den Bruel Annickdr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
The CCA Special Issue on Cardiovascular Markers.
Clin Chim Acta. 2020 [Editorial] doi: 10.1016/j.cca.2020.10.036dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe.
The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study. Clin Chim Acta 2020;511:59-66.dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe?
The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study. Chim Acta. 2020;508:267-272.dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?
Curr Cardiol Rep. 2020;22:67.dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Atherosclerosis 2020;294:46-61.dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Clin Chem Lab Med. 2020;58:496-517.dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Evolving concepts on the management of dyslipidaemia.
Acta Clin Belg – Int J Clin Lab Med 2020;75:80-90.dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Investigations on the clinical utility of apolipoprotein B measurement: A research priority.
Eur J Prev Cardiol. 2020;27:1252–1254 [Editorial].dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Muscle strength is a major determinant of the blood pressure response to isometric stress testing: the Asklepios population study.
J Hypertens 2020;38:224-234.dr. Langlois Michel01/01/2019
Laboratoriumgeneeskunde
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Atherosclerosis 2020 doi: 10.1016/j.atherosclerosis.2019.12.005.dr. Langlois Michel01/01/2019
Laboratoriumgeneeskunde
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Clin Chem Lab Med. 2019 doi: 10.1515/cclm-2019-1253.dr. Langlois Michel01/01/2019
Laboratoriumgeneeskunde
Evolving concepts on the management of dyslipidaemia.
Acta Clin Belg – Int J Clin Lab Med 2019 https://doi.org/10.1080/17843286.2019.1702823dr. Langlois Michel01/01/2020
Laboratoriumgeneeskunde
Muscle strength is a major determinant of the blood pressure response to isometric stress testing: the Asklepios population study.
J Hypertens 2020;38:224-234.dr. Langlois Michel01/01/2019
Laboratoriumgeneeskunde
Investigations on the clinical utility of apolipoprotein B measurement: A research priority.
Eur J Prev Cardiol. 2019 doi: 10.1177/2047487319869578dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
Evaluation of four hemoglobin separation analyzers for hemoglobinopathy diagnosis.
J Clin Lab Anal. 2018;32:e22224.dr. Devos Helenadr. Emmerechts Jandr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
Leukocyte telomere length and diet in the apparently healthy, middle-aged Asklepios population.
Sci Rep. 2018;8:6540.dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.
Clin Chem. 2018;64:1006-1033.dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
The Role of Nutraceuticals in Statin Intolerant Patients.
J Am Coll Cardiol. 2018;72:96-118.dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?
Curr Cardiol Rep. 2018;20:88.dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
Overview of the current status of familial hypercholesterolaemia care in over 60 countries – The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).
Atherosclerosis. 2018;277:234-255.dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
Atherosclerosis. 2018;277:369-376.dr. Langlois Michel01/01/2018
Laboratoriumgeneeskunde
Evaluation of Four Hemoglobin Separation Analyzers for Hemoglobinopathy Diagnosis.
Journal of Clinical Lab Analysis 2018;32(1)dr. Devos Helenadr. Emmerechts Jandr. Langlois Michel01/01/1970
Laboratoriumgeneeskunde
First EAS – EFLM consensus guideline on non-fasting lipid testing and reporting.
IFCC e-newsletter May-June 2016;20-21.dr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
Lipidentesten op niet-nuchtere bloedafnames.
Eur Heart J 2016 en Clin Chem 2016 namens de Europese EAS/EFLM expertgroepdr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
“Lipiden en lipoproteïnen” In: Wegwijs in Laboratoriumdiagnose.
Uitgeverij Acco 2016 p. 273-92. ISBN 978-94-6292-305-8.dr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
Haptoglobin phenotype and Parkinson disease risk.
Parkinsonism Relat Disord. 2016;22:108-9.dr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
Why are clinical practice guidelines not followed?
Clin Chem Lab Med. 2016;54:1133-9.dr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
Fasting is not routinely required for determination of a lipid profile-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
Eur Heart J. 2016;37:1944-58dr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).
Clin Chem. 2016;62:1264-71.dr. Langlois Michel01/01/2016
Laboratoriumgeneeskunde
Could accreditation bodies facilitate the implementation of medical guidelines in laboratories?
Clin Chem Lab Med. 2016 [Epub ahead of print]dr. Langlois Michel01/01/2015
Endocrinologie
Bone scan alterations in aromatase inhibitor-treated patients.
Clin Nuci Med. 2015 Jan;40(1):38-40.doi:10.1097/RLU.0000000000000588.dr. Van den Bruel Annickdr. De Geeter Frankdr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
HDL-gerichte therapieën: behandeling van een risicofactor of make-up van een risicomerker?
ISBN 978-90-81054-26-3 Transmed Medical Communications 2013 pp. 29-46.dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris Clin Biochem.
2013 [Epub ahead of print].dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Genetic aspects of scurvy and the European famine of 1845-1848
Nutrients 2013; 5:3582-8.dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Comparison of two immunoassays for measurement of faecal calprotectin in detection of Inflammatory Bowel Disease: (pre)-analytical and diagnostic performance characteristics.
Clin Chem Lab Med 2013 (in press).dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Guideline from the European Atherosclerosis Society: clinical view on laboratory checklist and issues
Biochimica clinica 2013; 375(Suppl.):S36dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation.
Clin Chem Lab Med. 2013; 51:1217-26.dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Pseudonephritis is Associated With High Urinary Osmolality and High Specific Gravity in Adolescent Soccer Players.
Pediatr Exerc Sci. 2013; 25:360-9dr. Langlois Michel01/01/2013
Laboratoriumgeneeskunde
Accuracy of three automated 25-hydroxyvitamin D assays in haemodialysis patients
Clin Chim Acta 2013; 415:255-60dr. Langlois Michel01/01/2012
Laboratoriumgeneeskunde
Is it time to apply genographics in medical diagnosis?
Acta Clin Belgica 2012;67:387-8.dr. Langlois Michel01/01/2012
Laboratoriumgeneeskunde
Human plasma protein polymorphisms and the persistence of cultural diversity.
Proc Natl Acad Sci U S A. 2012;109(43):E2914.dr. Langlois Michel01/01/2012
Laboratoriumgeneeskunde
How I treat dyslipidemia according to the cardiovascular risk profile?
Rev Med Liège 2012; 67:167-173.dr. Langlois Michel01/01/2012
Laboratoriumgeneeskunde
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels
PLoS ONE 2012;7:e32327dr. Langlois Michel01/01/2012
Laboratoriumgeneeskunde
Postanalytical opportunities of lipid and lipoprotein testing:laboratory approaches for predicting and managing risk of cardiovascular disease
Clin Chem Lab Med (invited article) 2012; 50:1169–1181.dr. Langlois Michel01/01/2012
Laboratoriumgeneeskunde
The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients
J Eur Acad Dermatol Venereol 2012; 26:566-71.dr. Langlois MichelLaboratoriumgeneeskunde
Predicting the development of coronary artery disease in apparently healthy individuals – the role of Lp(a)
2023-12-06dr. Langlois MichelLaboratoriumgeneeskunde
CASE REPORT: SPURIOUSLY HIGH VITAMIN A AND E LEVELS DUE TO HYPERLIPIDEMIA.
Virtual RBSLM Annual Meeting (Royal Belgian Society of Laboratory Medicine)dr. Langlois MichelLaboratoriumgeneeskunde
Update on Dyslipidaemia Guidelines and the rationale of Cardiovascular Disease Biomarker.
Barcelonadr. Langlois MichelLaboratoriumgeneeskunde
“Dyslipidemia- New clinical concepts and diagnostic tools”
Warschaudr. Langlois MichelLaboratoriumgeneeskunde
“Non-fasting lipid profiles: implications for lipoprotein measurement and reporting”
EFLM e-seminardr. Langlois MichelLaboratoriumgeneeskunde
LOK Cardiologie Richtlijnen en valkuilen bij het management van dyslipidemie
Bruggedr. Langlois MichelLaboratoriumgeneeskunde
Comparison of two extraction devices for determination of faecal calprotectin on ImmunoCAP250
Milaandr. Langlois MichelLaboratoriumgeneeskunde
Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris
Milaandr. Langlois MichelLaboratoriumgeneeskunde
Accuracy of three automated 25-hydroxyvitamin D immunoassays compared to ID-XLC-MSMS in haemodialysis patients
Milaandr. Langlois MichelLaboratoriumgeneeskunde
Accuracy of three automated immunoassays compared to ID-XLC-MSMS for the measurement of 25-hydroxyvitamin D in haemodialysis patients
Gentdr. Langlois MichelLaboratoriumgeneeskunde
EliA™ CTD screen: enzyme fluoroimmunoassay for ANA detection
Granadadr. Hutsebaut Isabeldr. Langlois Micheldr. Roggeman SylvieLaboratoriumgeneeskunde